New construction of PDL BioPharma (formally GenMab) manufacturing and support facilities to produce biopharmaceutical products, including a 98,000 SF cGMP plant housing two bioreactor production trains, media prep, buffer prep and utilities; a 32,000 SF warehouse/shipping facility; a 15,000 SF central utilities area; and a 55,000 SF two-story lab/administration building.